KBI Biopharma

Technologielaan 8

B-3001 Heverlee / Leuven

BE

KBI Biopharma

Foundation date

13/01/2018

Sector

#Biotechnology / R&D Services

Subsector

KBI Biopharma BV in Leuven is focused on providing analytical expertise for clients in need of formulation development and/or cGMP analytical services. Using a wide range of analytical methods we deliver the data that help our clients to conduct clinical studies or to release innovative biological products to patients in need.

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    20 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023